BioOrbit CEO on Developing Cancer Treatments in Zero Gravity

Katie King, cofounder and CEO of BioOrbit, said the company launched a mission to the International Space Station that produced protein crystals in microgravity at a scale one to two orders of magnitude larger than previous efforts. King discussed the milestone with Bloomberg's Tom Mackenzie.

Next story